SCHEMBL5800588

SCHEMBL5800588

CC(C)(C)CCCC(O)O

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 2/20 0.38
ACACB O00763 1/20 0.33
ACACA Q13085 1/20 0.33
TSHR P16473 1/20 0.30
ALDH1A1 P00352 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29692758 0.94 ACACB (0.40) RIPK1ACACBACACA
SCHEMBL28474839 0.92 ACACB (0.43) RIPK1ACACBACACA
SCHEMBL6245570 0.84
Adipic Acid SCHEMBL29443803 0.82 LMNA (0.46) TSHRALDH1A1
SCHEMBL14293914 0.81 ACACB (0.48) RIPK1ACACBACACATSHRALDH1A1
SCHEMBL8651499 0.79 ALDH1A1 (0.35) ACACBACACAALDH1A1
SCHEMBL25927335 0.79 RIPK1 (0.37) RIPK1ACACBACACATSHRALDH1A1
SCHEMBL1658860 0.79 RIPK1 (0.37) RIPK1ACACBACACATSHRALDH1A1
SCHEMBL25927332 0.79 RIPK1 (0.37) RIPK1ACACBACACATSHRALDH1A1
SCHEMBL17718583 0.77 ACACB (0.45) RIPK1ACACBACACA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250236757-A1 STRIP FREE FLOOR SYSTEM S. C. JOHNSON & SON, INC. 2025-07-24 US disclosed
CN-222942949-U Trimethyl pentanediol preparation is with distillation purification device 润泰化学(泰兴)有限公司 2025-06-06 CN disclosed
CN-113956132-B Preparation method of trimethylpentanediol 吉林化工学院 2024-03-19 CN disclosed
CN-112592666-B 360-DEG C-resistant high-temperature epoxy adhesive and preparation method and application thereof 康达新材料(集团)股份有限公司 2022-11-25 CN disclosed
CN-113956132-A Preparation method of trimethylpentanediol 吉林化工学院 2022-01-21 CN disclosed
WO-2006060885-A1 7-(2-CYCLOHEXYLIDENE-ETHYLIDENE)-SPIRO[5.5]UNDECANES USEFUL FOR MAKING PHARMACEUTICAL COMPOSITIONS K.U.LEUVEN RESEARCH & DEVELOPMENT (BE) 2006-06-15 WO disclosed
US-20050187221-A1 Method of treating ischemia reperfusion injury JAPAN TOBACCO INC. (JP) 2005-08-25 US disclosed
US-6174887-B1 Amide compounds and use of the same JAPAN TOBACCO INC. (JP) 2001-01-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050187221-A1 Method of treating ischemia reperfusion injury TNF, IL1B, TNNI3 RIPK1 866/4885ACACB 875/4885ACACA 789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.